Modern Medicine and the understanding of physiological and pathophysiological phenomena in terms of molecular and cellular bioscience (as e.g.: medical biophysics & biochemistry, cell biology, molecular and cellular physiology, medical genetics) are intimately related. In order to effectively improve human health, scientific discoveries at the molecular and cellular level must be translated into practical application. Typically, such discoveries begin at “the bench” with basic research – then progress to the clinical level, or the patient’s “bedside”. Scientists are increasingly aware that this bench-to-bedside approach of translational molecular and cellular bioscience research is indeed a bidirectional process: basics scientists provide clinicians with new tools for use in patients and for assessment of their impact and on the other side clinical researchers make novel observations about the nature and progression of disease – that often stimulates basic investigations. Translational research, especially at the molecular and cellular level, has proven to be a powerful process that drives the clinical, as well as the preclinical research engine.
In order to promote this purpose at the graduate level, Medical University in Graz has established a corresponding Doctoral School. Doctoral candidates must hold a Master´s degree or equivalent in Medicine, Natural Sciences or Engineering. English is the principal language used for teaching, communication and writing of the Thesis and thus, excellent English skills are required. Graduates of the Doctoral program in “Translational Molecular and Cellular Bioscience” will hold the academic degree “Doctor of Medical Sciences (Dr. sci. med)” that is entirely pursuant to the Bologna process of the European Higher Education Area (EHEA; equivalent to the general terms “Doctorate” or “PhD”).